Acadian Asset Management LLC Glycomimetics Inc Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 357,439 shares of GLYC stock, worth $82,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
357,439
Previous 534,753 33.16%
Holding current value
$82,210
Previous $150,000 60.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$0.16 - $0.32 $28,370 - $56,740
-177,314 Reduced 33.16%
357,439 $59,000
Q2 2024

Aug 06, 2024
BUY
$0.24 - $3.04 $49,014 - $620,850
204,227 Added 61.79%
534,753 $150,000
Q1 2024

May 10, 2024
SELL
$2.55 - $3.49 $537,157 - $735,168
-210,650 Reduced 38.92%
330,526 $991,000
Q4 2023

Feb 13, 2024
SELL
$1.13 - $2.54 $342,248 - $769,302
-302,875 Reduced 35.88%
541,176 $1.28 Million
Q3 2023

Nov 13, 2023
SELL
$1.29 - $1.73 $394,230 - $528,696
-305,605 Reduced 26.58%
844,051 $1.27 Million
Q2 2023

Aug 07, 2023
SELL
$1.21 - $2.08 $304,916 - $524,153
-251,997 Reduced 17.98%
1,149,656 $2 Million
Q1 2023

May 11, 2023
SELL
$1.25 - $4.05 $676,756 - $2.19 Million
-541,405 Reduced 27.86%
1,401,653 $1.77 Million
Q4 2022

Feb 14, 2023
SELL
$0.57 - $3.03 $26,806 - $142,497
-47,029 Reduced 2.36%
1,943,058 $5.89 Million
Q1 2022

May 12, 2022
BUY
$1.0 - $1.58 $39,001 - $61,621
39,001 Added 2.0%
1,990,087 $2.27 Million
Q4 2021

Feb 10, 2022
BUY
$1.44 - $2.14 $93,598 - $139,097
64,999 Added 3.45%
1,951,086 $2.81 Million
Q3 2021

Nov 12, 2021
SELL
$1.8 - $2.39 $118,089 - $156,795
-65,605 Reduced 3.36%
1,886,087 $4.13 Million
Q2 2021

Aug 11, 2021
BUY
$2.16 - $3.18 $661,817 - $974,342
306,397 Added 18.62%
1,951,692 $4.53 Million
Q1 2021

May 11, 2021
BUY
$2.89 - $4.22 $2.41 Million - $3.53 Million
835,611 Added 103.2%
1,645,295 $4.95 Million
Q4 2020

Feb 11, 2021
BUY
$2.69 - $4.24 $1.02 Million - $1.61 Million
378,647 Added 87.85%
809,684 $3.04 Million
Q3 2020

Nov 09, 2020
BUY
$3.07 - $5.0 $507,044 - $825,805
165,161 Added 62.12%
431,037 $1.32 Million
Q2 2020

Aug 12, 2020
BUY
$2.06 - $3.76 $540,739 - $986,981
262,495 Added 7763.83%
265,876 $1 Million
Q4 2019

Feb 06, 2020
SELL
$4.03 - $6.5 $52,317 - $84,383
-12,982 Reduced 79.34%
3,381 $18,000
Q3 2019

Nov 07, 2019
BUY
$2.8 - $12.85 $45,816 - $210,264
16,363 New
16,363 $71,000

Others Institutions Holding GLYC

# of Institutions
36
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About GLYCOMIMETICS INC

GLYC Quotes by TradingView
  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $12.1M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email